Evidence map›Paper›PMID 41706168›Full record

ReviewCurrent microbiology2026

Exploring Bifidobacteria-Fermented Dairy Products: Innovations, Challenges, and Health-Related Insights.

Guoxuan Hang, Yuanyuan Guo, Weicheng Li

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Guoxuan HangKey Laboratory of Dairy Biotechnology and Engineering (IMAU), Ministry of Education, Inner Mongolia Agricultural University, Hohhot, P.R. China.
Yuanyuan GuoKey Laboratory of Dairy Biotechnology and Engineering (IMAU), Ministry of Education, Inner Mongolia Agricultural University, Hohhot, P.R. China.
Weicheng LiKey Laboratory of Dairy Biotechnology and Engineering (IMAU), Ministry of Education, Inner Mongolia Agricultural University, Hohhot, P.R. China. liweicheng0011@163.com.ORCID http://orcid.org/0000-0001-9880-9390

Funding

China Agricultural Research System CARS-36Natural Science Foundation of Inner Mongolia Autonomous Region of China 2024QN03030the First-class scientific research projects of Inner Mongolia Autonomous Region of China YLXKZX-NND-015
6 · The paper itself

Abstract

Bifidobacteria are extensively used as probiotics in products owing to their significant health benefits in humans. These products function as effective delivery systems, bridging the gap between probiotics and the well-being of the host. This review provides a comprehensive overview of the existing challenges associated with the use of bifidobacteria in fermented dairy products, particularly focusing on the factors impending their viability and strategies for enhancing their stability. Additionally, this review explores the impact of bifidobacteria-enriched dairy products on immune system modulation and their influence on the gut-brain axis via modifications in the gut microbiota composition. The insights presented in this review will contribute to the progress of bifidobacteria-enriched dairy products in both industrial applications and scientific research.

Indexed as

BifidobacteriumCultured Milk ProductsDairy ProductsProbioticsAnimalsFermentationHumansBifidobacteriaFermented dairy productsProbiotic propertiesStress responseViability

Identifiers

PMID41706168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.